688393.SH
Guangzhou LBP Medicine Science & Technology Co., Ltd.
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 19.04
+3.53%Year over year
Reported trailing growth
- Revenue
- -20.5%
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- -45.7%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -12.1%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- +183.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026